Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

A2A/A1 AR antagonist-1

A2A/A1 AR antagonist-1 (compound 1a) is a potent dual antagonist of adenosine A2A and A1 receptors, exhibiting Kis of 5.58 nM and 24.2 nM, respectively. It is a valuable research tool for investigating neuroprotective strategies in models of ischemic stroke, applicable in both in vitro and in vivo experimental settings.

Product Specifications

CAS Number

2445615-24-5

Field of Research

Neuroscience, Pharmacology & Drug Discovery

Smiles

NC=1N2C (C (=CN1) C3=CN (C) C (=O) C=C3) =NC (=N2) C4=CC=CO4

Molecular Formula

C15H12N6O2

Molecular Weight

308.29

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Rabbit anti-Saccharomyces cerevisiae (strain 204508/S288c)(Baker's yeast) HNT3 Polyclonal Antibody
MBS7147524 Inquire

Rabbit anti-Saccharomyces cerevisiae (strain 204508/S288c)(Baker's yeast) HNT3 Polyclonal Antibody

Sign In for Pricing
View Details
F8A1 sgRNA CRISPR Lentivector set (Human)
K0707101 3x 1.0 µg

F8A1 sgRNA CRISPR Lentivector set (Human)

Sign In for Pricing
View Details
CITED1 (Cbp/p300-Interacting transactivator, with Glu/Asp-Rich carboxy-terminal Domain, 1, MSG1) (MaxLight 550)
MBS6216332-01 0.1 mL

CITED1 (Cbp/p300-Interacting transactivator, with Glu/Asp-Rich carboxy-terminal Domain, 1, MSG1) (MaxLight 550)

Sign In for Pricing
View Details
CITED1 (Cbp/p300-Interacting transactivator, with Glu/Asp-Rich carboxy-terminal Domain, 1, MSG1) (MaxLight 550)
MBS6216332-02 5x 0.1 mL

CITED1 (Cbp/p300-Interacting transactivator, with Glu/Asp-Rich carboxy-terminal Domain, 1, MSG1) (MaxLight 550)

Sign In for Pricing
View Details
Recombinant MYO5C Antibody
RN-014-01 50 μL

Recombinant MYO5C Antibody

Sign In for Pricing
View Details
Recombinant MYO5C Antibody
RN-014-02 100 µL

Recombinant MYO5C Antibody

Sign In for Pricing
View Details